AI Article Synopsis
- Acute myeloid leukemia (AML) is a type of blood cancer with unclear genetic risk factors, and this study explores its hereditary aspects through a meta-analysis.
- Researchers analyzed data from four studies involving 4,018 AML patients and 10,488 controls, finding significant genetic risk loci at two locations: 11q13.2 related to KMT5B and 6p21.32 related to HLA.
- The study enhances understanding of AML development and highlights the roles of genes linked to histone methylation and immune response.
Article Abstract
Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 10488 controls. We identify a genome-wide significant risk locus for AML at 11q13.2 (rs4930561; P = 2.15 × 10; KMT5B). We also identify a genome-wide significant risk locus for the cytogenetically normal AML sub-group (N = 1287) at 6p21.32 (rs3916765; P = 1.51 × 10; HLA). Our results inform on AML etiology and identify putative functional genes operating in histone methylation (KMT5B) and immune function (HLA).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556284 | PMC |
| http://dx.doi.org/10.1038/s41467-021-26551-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!